Results 131 to 140 of about 4,232,192 (254)

Controlled release of CD200 inhibits inflammatory macrophages and chondrocyte catabolism. [PDF]

NPJ Biomed Innov
Kumar S, Patterson FM, Conklin T, Hsu SJ, Meli V, Chan K, Allen KD, Liu WF, Sharma B.   +8 more
europepmc   +1 more source

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

Molecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge, Morten Tulstrup, Gabriele Todisco, Pedro Moura, Christophe Côme, Jakob Werner Hansen, Jakob Schmidt Jespersen, Balthasar Schlotmann, Maria Creignou, Mette Dahl, Claudia Schöllkopf, Klas Raaschou‐Jensen, Krister Wennerberg, Bo Porse, Joachim Weischenfeldt, Eva Hellström‐Lindberg, Lasse Sommer Kristensen, Kirsten Grønbæk   +17 more
wiley   +1 more source

Smart mesoporous silica nanoparticles for precision cancer therapy: Tumor targeting and stimuli-responsive controlled release. [PDF]

Smart Mol
Al-Amili M, Lei L, Jin Z.
europepmc   +1 more source

Hydrogel-Based Crss Analyses: Testing And Modeling [PDF]

, 2015
CASCONE, SARA, BARBA, Anna Angela, CACCAVO, DIEGO, LAMBERTI, Gaetano   +3 more
core  

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source

Remote-Controlled Release of Nitric Oxide by Plasmonic Waveguide Coated With Metal-Organic Frameworks. [PDF]

Small
Inose T, Lopez-Cabrelles J, Troyano J, Tokuda S, Sánchez-González E, Takahashi N, Mori Y, Hirai K, Uji-I H, Furukawa S.   +9 more
europepmc   +1 more source

Hyaluronate - Gold Nanoparticle / Tocilizumab Complex for Combination Therapy of Rheumatoid Arthritis

, 2014
1
한세광
core  

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

Preparation, characterization, and performance evaluation of a controlled-release inhibitor-enhanced nitrogen fertilizer. [PDF]

Front Plant Sci
Gao F, An Z, Wang J, Qiu W, Sun S, Wang H, Chen Y, Pan J, Dong Y, Zhou X, Xie Y, Lv J, Xiao Q.   +12 more
europepmc   +1 more source

Hyaluronate - Upconversion Nanoparticle Conjugate for Deep Tissue Photomedicine

, 2016
1
한세광
core